Tradestie Institutional Equity Comparison Engine
UCC vs RXL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RXL Overall Edge
RXL Captures Institutional Edge (1โ0 Pillars ยท 3โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProShares Ultra Health Care (RXL) driven by superior Momentum & Technical. Fundamentally, UCC trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RXL at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, UCC sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against RXL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
UCC N/M vs RXL N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
RXL
1Y -9.2% vs +42.0% ยท 52W Pos 40% vs 89%
Options & Structure Winner
Tie
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (<1st %ile IV)
UCC
NYSE Arca
ProShares Ultra Consumer Discretionary
Institutional Equity
$46.68
-3.2% 1D
Market Cap
N/A
1M Return
+8.88%
1Y Return
-9.23%
Forward P/E
N/M
Unified AI Score
31.8 / 100
SELL
Tech 8.0
Fund 25.0
Flow 50.0
Mom 21.1
RXL
NYSE Arca
ProShares Ultra Health Care
Institutional Equity
$71.98
-1.1% 1D
Market Cap
N/A
1M Return
+12.08%
1Y Return
+41.97%
Forward P/E
N/M
Unified AI Score
40.0 / 100
SELL
Tech 18.0
Fund 30.0
Flow 50.0
Mom 21.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
UCC -9.23%
RXL +41.97%
Spread: +47.93 pp (RXL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
UCC TTM Op. Margin: N/A
RXL TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UCC vs RXL. Trailing 12-month operating profitability (UCC N/A vs RXL N/A) and valuation multiples (UCC N/M vs RXL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UCC | RXL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 40% ($40โ$57) | 89% ($43โ$76) | Stronger Trend | RXL |
| Beta / 30D Volatility Risk Regime | 2.19ฮฒ ยท 52% Vol | 0.54ฮฒ ยท 41% Vol | Lower Realized Risk | RXL |
| Unified Institutional Score Composite Signal | 31.8 / 100 (SELL) | 40.0 / 100 (SELL) | Higher Composite | RXL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full UCC vs RXL Buy Guide
UCC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
RXL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither UCC nor RXL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.